De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Irwin Naturals Beheer
Beheer criteriumcontroles 0/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Klee Irwin
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 3yrs |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | less than a year |
Recente managementupdates
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$20m |
Jun 30 2023 | n/a | n/a | -US$19m |
Mar 31 2023 | n/a | n/a | -US$13m |
Dec 31 2022 | US$306k | US$295k | -US$4m |
Sep 30 2022 | n/a | n/a | US$4m |
Jun 30 2022 | n/a | n/a | US$3m |
Mar 31 2022 | n/a | n/a | US$6m |
Dec 31 2021 | US$259k | US$248k | US$9m |
Sep 30 2021 | n/a | n/a | US$7m |
Jun 30 2021 | n/a | n/a | US$11m |
Mar 31 2021 | n/a | n/a | US$10m |
Dec 31 2020 | US$75k | US$69k | US$7m |
Compensatie versus markt: Insufficient data to establish whether Klee's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensatie versus inkomsten: Klee's compensation has increased whilst the company is unprofitable.
CEO
Klee Irwin (58 yo)
3yrs
Tenure
US$305,593
Compensatie
Mr. Klee Irwin is Chairman and Chief Executive Officer at Irwin Naturals Inc and is its Director since August 2021. He has been Chief Executive Officer and President of Omni Nutraceuticals since March 12,...
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman & CEO | 3yrs | US$305.59k | geen gegevens | |
Director | less than a year | geen gegevens | geen gegevens | |
Director | less than a year | geen gegevens | geen gegevens |
0.5yrs
Gemiddelde duur
Ervaren bestuur: IWIN's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.